AIDSWEEKLY Plus; Monday, July 16, 2007
Staff Medical Writers

The District, along with the rest of the nation, will continue to be forbidden from spending Federal funding on syringe exchange programs. Syringe exchanges are a method of HIV prevention which helps intravenous drug users attain clean needles in order to prevent sharing needles that are potentially infected with HIV/AIDS, Hepatitis A, B or C or other bloodborne diseases.

In 2005, Washington, DC had the highest rate of AIDS cases in the country, 128.4 per 100,000 vs. 19.7 per 100,000, nationally — nearly 1 out of every 50 residents has AIDS, and it is estimated that nearly 1 out of every 20 is infected with HIV.

In Washington, DC, injection drug use is directly responsible for 35% of the all AIDS cases and 54% of AIDS cases in women since the beginning of the epidemic. AIDS Action commends the House of Representatives for its historic vote and particularly applauds Representatives Eleanor Holmes Norton (D-DC), Jose Serrano (D-NY) and David Obey (D-WI) for their strong leadership in removing the ban.

"The Federal government certified in 1998 that syringe exchange reduces the transmission of HIV infections and does not raise the level of drug abuse," said Ronald Johnson, Deputy Executive Director of AIDS Action. He continued, "The District of Columbia has the highest HIV rates in the entire nation and injection drug use is directly responsible for 35% of all AIDS cases in the District along with 54% of AIDS cases in women in the District since the beginning of the epidemic. District residents truly need the resources that the Washington, DC government can provide for syringe exchange."

The House voted 216 to 208 to oppose an amendment to restore the ban on the District's local funding. "This is an historic vote," said Mr. Johnson. "It is the first direct House floor vote on syringe exchange issues since 2000 and the first vote to favor syringe exchange. We call on the Senate to follow suit as soon as possible and ensure that Washington, D.C. is able to join almost every other major city in this country in supporting locally funded syringe exchange programs. This vote is a tremendous victory. Hopefully it will eventually lead to lower HIV rates among intravenous drug users in the city," he said. Editor's note: See talking points from AIDS Action below.

Keywords: HIV/AIDS, AIDS, Acquired Immunodeficiency Syndrome, HIV, Human Immunodeficiency Virus, Virology, AIDS Action.

This article was prepared by AIDS Weekly editors from staff and other reports.

2007-07-16
AW070709

Copyright © 2007 - Charles Henderson, Publisher. All rights Reserved. Permission to reproduce granted to AEGIS by Charles W. Henderson. Authorization to reproduce for personal use granted granted by C. W. Henderson, Publisher, provided that the fee of US$4.50 per copy, per page is paid directly to the Copyright Clearance Center, 27 Congress Street, Salem, Massachusetts 01970, USA. Published by Charles Henderson, Publisher. Editorial & Publishing Office: P.O. Box 5528, Atlanta, GA 30307-0528 / Telephone: (800) 633-4931; Subscription Office: P.O. Box 830409, Birmingham, AL 35283-0409 / FAX: (205) 995-1588 http://www.newsrx.net

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, Bridgestone/Firestone Charitable Trust, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright © 1980,2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.